Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
Bat genes could hold clues for cancer treatment
Scientists believe bat genes may provide clues to treating human diseases

New research published in this month's edition of Science examines the viruses carried by bats, their relatively long lives and the evolution of flight. Scientists believe that a deeper understanding of these could provide clues for preventing and treating infectious diseases and cancer in humans.

The researchers from CSIRO (Australia's national science research agency) and the Beijing Genome Institute, led a team sequencing the genomes of two bat species - an Australian mega bat, the black flying fox, and a Chinese micro bat, David's myotis. The teams then compared the bat genomes to the genomes of eight other mammals, including humans.

Chris Cowled, post-doctoral fellow at CSIRO's Australian animal health laboratory said that despite the fact that bats carry several lethal diseases, such as Hendra, Ebola and SARS, "they don't often succumb to disease from these viruses." As well as this they live relatively long lives in comparison to other animals of similar size, and are the only mammal that can fly.

Cowled added: "A deeper understanding of these evolutionary adaptations in bats may lead to better treatments for human diseases, and may eventually enable us to predict or even prevent outbreaks of emerging bat viruses."

According to Cowled, bats have "some novel genes" to deal with the toxins produced as by-products of flying. Some of these genes, such as P53, are implicated in the development of cancer, and the detection and repair of damaged DNA.

Cowled explains: "What we found intriguing was that some of these genes also have secondary roles in the immune system. We're proposing that the evolution of flight led to a sort of spill over effect, influencing not only the immune system, but also things like ageing and cancer."

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.